Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1669.20
-31.35 (-1.84%)
< Home < Back

Sun Pharmaceutical Industries informs about press release

Date: 14-06-2024

Sun Pharmaceutical Industries has informed that it enclosed a copy of the Press Release about Oral Presentation at EULAR 2024 of Data from Global Phase 2b Clinical Trial of MM-II in Patients with Painful Knee Osteoarthritis (OA), which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.